Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
UCB SA (UCB BB)
Watchlist
20
Analysis
Health Care
•
Belgium
UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Tencent
•
04 May 2024 00:35
Upgrading Emerging Markets to Market Weight; China/Hong Kong Continue to Bottom; Energy Breakdowns
Upgrading Emerging Markets $EEM $VWO to Market Weight; China/Hong Kong Continue to Bottom $FXI $MCHI $KWEB; Lows Likely in on $ACWI; Commodities...
Vermilion Research
Follow
443 Views
Share
bullish
•
SK Biopharmaceuticals
•
20 Jul 2023 18:38
SK Biopharmaceuticals (326030 KS): Starts 2023 on Strong Note; Unveils New Mid to Long-Term Strategy
In 1Q23, SKBP recorded Xcopri U.S. revenue of KRW53.9B, up 70% YoY and 8% QoQ. Xcopri sales are expected to accelerate in H2. SKBP aims to become a...
Tina Banerjee
Follow
504 Views
Share
bearish
•
iShares MSCI ACWI ETF
•
29 Apr 2023 00:37
Stay Tactically Overweight Defensives; Remain Overweight Europe, Japan, & EAFE. Buys in Defensives
$93 on $ACWI continues to be a key resistance that we have discussed since early-Jan as capping upside for 2023. Stick with defensives $IXJ $XLV...
Vermilion Research
Follow
407 Views
Share
bullish
•
iShares Global Healthcare ETF
•
07 Apr 2023 06:47
Defensives Worthy of a Tactical Overweight; Buys in Global Health Care, Gold Miners, and Utilities
We have recommended shifting to defensives throughout Feb/March due to our belief that $93 will cap upside on $ACWI. We highlight buys within...
Vermilion Research
Follow
643 Views
Share
bearish
•
iShares MSCI ACWI ETF
•
01 Apr 2023 03:39
Shift To Defensives as $ACWI Makes Push for $93; Remain Overweight Europe; Opptys in China/HK, Japan
$ACWI, $ACWX, $EFA, and $EEM all reversing topside their 2-month downtrends. Despite this bullish short-term development, we still expect $93 to...
Vermilion Research
Follow
477 Views
Share
Previous
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.1
x